The Medical Supply Chain Resiliency Act is designed to empower the President to negotiate trade agreements that eliminate tariffs and other import restrictions on medical goods, thereby enhancing national security and public health in the United States. This initiative is particularly relevant in light of the challenges exposed by the COVID-19 pandemic, aiming to create a more robust and reliable supply chain for essential medical supplies.